Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Origanum majorana organic extract (OME) is a botanical extract derived from *Origanum majorana* (marjoram), a perennial herb widely used as a culinary spice. Developed by researchers at Florida International University, OME is being investigated for its potential antineoplastic activity, particularly in breast cancer. Preclinical studies indicate that OME inhibits the proliferation of breast cancer cells (such as MCF-7 and MDA-MB-231) by disrupting mitochondrial bioenergetics, reducing ATP production, and inducing senescence, apoptosis, and autophagic cell death.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on origanum majorana organic extract.